Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-30

FDA Approved: LABETALOL HYDROCHLORIDE — Original Application (Epic Pharma, LLC)

View source ↗

Summary

FDA approved the original application for a generic labetalol hydrochloride product from Epic Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Labetalol Hydrochloride (Labetalol hydrochloride)

Snippet

ORIG AP for LABETALOL HYDROCHLORIDE (LABETALOL HYDROCHLORIDE)